Alzprotect

Calculating rank

USPTO Granted Patents = 6

EPO Patents = 5

Trademarks = 1

Forward Citations = 2

Loading Chart...

15 inventors (with patents filed for the assignee):

Cécilia Estrella (5 out of 5 patents)

Philippe Verwaerde (5 out of 5 patents)

Nicolas Sergeant (4 out of 12 patents)

4. Stéphane Burlet (4 out of 4 patents)

5. Mathieu Barrier (4 out of 4 patents)

6. Patricia Melnyk (4 out of 10 patents)

7. Luc Buee (3 out of 8 patents)

8. Saurabh Chitre (1 out of 4 patents)

9. Pascal Carato (1 out of 3 patents)

10. Emilie Nguyen (1 out of 1 patent)

11. Stephane Burlet (1 out of 2 patents)

12. Cyrille Brantis (1 out of 1 patent)

13. Noëlle Callizot (1 out of 3 patents)

14. Jonathan Loughrey (1 out of 2 patents)

15. Gavin Pringle (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 12790305 - Succinate salts of n-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H- benzo[d]imidazol-2-amine, preparation thereof and use of the same (2026-11-10),

2. 12629368 - USE OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1H-BENZO[D]IMIDAZOL-2-AMINE SULPHATE SALTS AND SOLVATES THEREOF FOR THE TREATMENT OF MOTOR NEURON DISEASES AND NEUROMUSCULAR JUNCTION DISORDERS (2026-05-19),

3. 10772884 - Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same (2020-09-15),

4. 10537569 - Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same (2020-01-21),

5. 9714245 - Carboline compounds usable in the treatment of neurodegenerative diseases (2017-07-25),

6. 9562018 - Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine, preparation thereof and use of the same (2017-02-07),

Company Overview

Alzprotect is a biopharmaceutical company focused on developing innovative drug candidates for the treatment of neurodegenerative diseases, with a primary focus on Alzheimer's disease. Their mission is to provide groundbreaking therapies that offer hope to patients and their families. Alzprotect's team of experts are dedicated to advancing research and clinical development to address the growing need for effective treatments in this area.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

6 Patents

#2 in Loos

#2,493 in France

Loos, France

Alzprotect

Forward Citations = 2

15 inventors:

Cécilia Estrella (5 out of 5 patents)

Philippe Verwaerde (5 out of 5 patents)

Nicolas Sergeant (4 out of 12 patents)

4. Stéphane Burlet (4 out of 4 patents)

5. Mathieu Barrier (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Alzprotect. Retrieved from https://idiyas.com/company/alzprotect

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

5 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]